课题基金 / 基金详情

Analysis of modified structures of transthyretin, elucidation of disease etiology of amyloidosis and application to clinical laboratory tests

Analysis of modified structures of transthyretin, elucidation of disease etiology of amyloidosis and application to clinical laboratory tests
转甲状腺素蛋白的修饰结构分析、淀粉样变性病病因的阐明及其在临床实验室检测中的应用
批准号:
16590466
负责人:
SHIMIZU Akira
金额:
$2.3万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2005

项目摘要

项目成果

SHIMIZU Akira的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
During the process of transthyretin (TTR) analysis, we found unique modified forms of TTR ; those are S-sulfo-TTR and TTR with the substitution of cysteine at position 10 by glycine. To clarify the generation process of these unique derivatives in vitro, we analyzed commercially purchased TTR and synthetic peptide with the same sequence as the cysteine-containing part of TTR, i.e., SKCPLMVK, after incubation at pH 8.3. Changes in the molecular weights and amino acid sequences of peptides were analyzed by LC/ESI-MS. Both experiments showed that various derivatives were generated, which revealed substitutions of the cysteine residue to glycine, dehydroalanine, S-thiocysteine, and S-sulfocysteine residues, which were confirmed by molecular mass and collision induced dissociation spectra. The existence of the TTR derivatives suggests that transformation starts from a β-elimination of a disulfide linkage to dehydroalanine and S-thiocysteine. The TTR and peptides were hydrolysed with HCl and analysed by amino acid analysis. We failed to confirm the increase of glycine and generation of new amino acids such as lanthionine.Commercially purchased TTR and serum TTR were denatured and reduced. These were analyzed by SDS-PAGE and MALDI-TOFMS. Both showed bands corresponding to a monomer, dimer, 60kDa, 45kDa, 28kDa, and 20kDa polymers by SDS-PAGE. In addition to these, serum TTR showed a 55kDa component. The content of polymers was more than 10% in purified TTR and serum TTR by SDS-PAGE. However, by MALDI-TOFMS, no polymer components were observed. The solvent for MALDI-TOFMS was a strong acid but did it not contain SDS. TTR might form non-covalent polymers in reagents for denaturation such as SDS. Further studies are necessary to elucidate the possible relationships among dehydroalanine generation, non-covalent polymerization, and amyloido-fiber formation of TTR molecules.
期刊论文(28)
专著(0)
科研奖励(0)
会议论文
New approaches towards laboratory diagnosis of isolated sulfite oxidase deficiency
分离亚硫酸氧化酶缺乏症实验室诊断的新方法
DOI: --
发表时间: 2004
期刊: Annals of Clinical Biochemistry 41
影响因子: --
作者: [J.O.Sass, T Nakanishi, T Sato, A Shimizu]
通讯作者: A Shimizu
Hb KOCHI [β141(H19)Leu→Val (g.1404 C→G) ; 144-146(HC1-3)Lys-Tyr-His→0 (g.1413 A→T)] : A NEW VARIANT WITH INCREASED OXYGEN AFFINITY.
Hb KOCHI [β141(H19)Leu→Val (g.1404 C→G) ; 144-146(HC1-3)Lys-Tyr-His→0 (g.1413 A→T)]:氧含量增加的新变体亲和力。
DOI: --
发表时间: 2005
期刊: Hemoglobin 29(1)
影响因子: --
作者: [A Miyazaki, T Nakanishi, A Shimizu, M Mizobuchi, Y Yamada, K Imai]
通讯作者: K Imai
DOI: --
发表时间: 2004
期刊: Journal of Chromatography B 806
影响因子: --
作者: [Iguchi, K., Nakanishi, T., Miyazaki, A., Shimizu, A., Ota, A]
通讯作者: A
Detection and characterization of variant and modified structures of proteins in blood and tissues by mass spectrometry.
通过质谱法检测和表征血液和组织中蛋白质的变异和修饰结构。
DOI: --
发表时间: 2006
期刊: Mass Spectrom Rev 25
影响因子: --
作者: [Shimizu A, Nakanishi T, et al.]
通讯作者: et al.
11
    Elevated type I interferon expression in dermatomyositis: involvement of LINE-1 and viral infection.
    Statistical mechanics based on pure quantum states
    • 批准号:
      26287085
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.32万
    • 财政年份:
      2014
    • 负责人:
      SHIMIZU Akira
    • 依托单位:
    A Study on Developing English, Chinese and Malay Teaching Materials Based on Communicating in Laboratories of Electronics
    • 批准号:
      26370690
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.58万
    • 财政年份:
      2014
    • 负责人:
      SHIMIZU Akira
    • 依托单位:
    Immunological network in ANCA associated glomerulonephritis
    • 批准号:
      24591217
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.41万
    • 财政年份:
      2012
    • 负责人:
      SHIMIZU Akira
    • 依托单位:
    海外基金